Human Immunoglobulin (Ph4) For Intravenous Injection Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Primary Immunodeficiency Diseases
The Human Immunoglobulin (pH4) for Intravenous Injection Market is estimated to be valued at US$ 61.6 Bn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Read More